A proteomic map of B cell activation and its shaping by mTORC1, MYC and iron

This study utilizes high-resolution mass spectrometry to map the extensive proteomic remodeling of B cells during activation, revealing how mTORC1, MYC, and iron availability coordinately regulate metabolic machinery, amino acid transport, and cellular growth to drive protein production.

The Gist

Imagine a B cell as a quiet, small workshop sitting in a factory (your body). In its normal, resting state, this workshop is efficient but modest. It has just enough tools to keep the lights on, but it's not building anything massive.

Now, imagine the workshop receives an urgent alarm: "Invader detected! Build antibodies immediately!" This is what happens when your immune system spots a virus or bacteria. The B cell wakes up, and this paper is essentially a detailed blueprint of how that workshop transforms into a massive, high-speed construction site.

Here is the story of that transformation, broken down into simple parts:

1. The Great Expansion (The "5-Fold" Growth)

When the alarm sounds, the B cell doesn't just tweak a few things; it goes into overdrive. Within 24 hours, the cell grows five times bigger and its total "stuff" (proteins) increases by the same amount.

• The Analogy: It's like a small bakery suddenly needing to supply a whole city. It doesn't just bake one extra loaf; it builds new ovens, hires more bakers, and expands the building itself. The paper found that the cell swaps out its "maintenance crew" (quiet proteins) for a "construction crew" (ribosomes and machinery) to build proteins at a frantic pace.

2. The Supply Chain Crisis (Fueling the Fire)

You can't build a skyscraper without bricks, steel, and concrete. Similarly, the B cell needs massive amounts of nutrients (amino acids, sugar, iron) to build its new proteins.

• The Analogy: The paper discovered that the B cell installs super-highways to bring in supplies. It dramatically increases the number of "trucks" (transporters) on its surface to haul in amino acids and sugar.
• The Iron Connection: One specific "truck" is the Transferrin Receptor (CD71), which hauls in Iron. The study found that the cell's demand for iron jumps 7-fold! Without enough iron, the construction site grinds to a halt, and the cell can't grow.

3. The Bosses in Charge (mTORC1 and MYC)

Who is giving the orders to build these highways and expand the factory? The paper identifies two main "Bosses":

• Boss 1: mTORC1. Think of this as the Site Manager. It senses if there are enough nutrients. If the manager says "Go," the cell starts building. If you stop the manager (using a drug called Rapamycin), the construction stops. The highways close, the iron trucks stop, and the cell stays small.
• Boss 2: MYC. This is the Architect. It draws the blueprints for growth. Interestingly, the Site Manager (mTORC1) often tells the Architect (MYC) what to do. If you stop the Architect, the cell also stops growing, but there's a twist: the Architect doesn't control every truck. Some nutrient trucks are controlled directly by the Site Manager, not the Architect.

4. Different Types of Alarms (T-Dependent vs. T-Independent)

The paper also looked at how the cell reacts to different types of alarms.

• The "Team Alarm" (T-cell dependent): This is like a complex, coordinated attack requiring a meeting with a T-cell. It triggers a massive, full-scale expansion. The cell goes all out, building everything it needs for a long-term defense.
• The "Solo Alarm" (T-cell independent): This is a simpler, faster alarm (like a direct hit from bacteria). The cell still grows, but it's more like a quick renovation rather than a full expansion. It's less dramatic but still effective.

5. The Takeaway

This research is like a master map of the B cell's internal world. Before this, we knew the cell grew, but we didn't know exactly which tools were being used or who was holding the clipboard.

In simple terms:

• B cells are immune factories that explode in size when fighting infection.
• They need Iron and Amino Acids to do this, and they build massive "highways" to get them.
• The mTORC1 and MYC proteins are the bosses that turn these highways on.
• If you block these bosses or run out of Iron, the factory shuts down, and the immune system can't fight back effectively.

This map helps scientists understand how to boost the immune system (by feeding it the right fuel) or calm it down (by blocking the bosses) in diseases like autoimmunity or cancer.

Technical Summary

1. Problem Statement

B lymphocytes (B cells) are central to the adaptive immune system, requiring rapid metabolic reprogramming and massive protein synthesis upon activation to differentiate into antibody-secreting plasma cells or memory cells. While the transcriptional changes and the role of the metabolic kinase mTORC1 in B cell function are partially understood, the quantitative landscape of the proteome during activation remains largely unmapped. Specifically, there is a lack of data regarding:

• The absolute copy numbers of proteins driving B cell growth.
• The specific metabolic machinery (nutrient transporters, mitochondrial remodeling) required to fuel this expansion.
• The mechanistic interplay between mTORC1, the transcription factor MYC, and iron availability in regulating these processes.
• The differences between T cell-dependent (via BCR/CD40) and T cell-independent (via TLR4) activation pathways.

2. Methodology

The study employed high-resolution quantitative mass spectrometry (MS) to generate a deep proteomic map of primary murine B cells.

• Sample Preparation: Primary naïve B cells were isolated from C57BL/6 mice (and specific knockout models: Slc7a5^fl/flVav^Cre, Myc^fl/flCd19^Cre, and Myc-GFP reporters). Cells were stimulated for 24 hours with:
  • T cell-dependent stimuli: Anti-IgM (BCR), Anti-CD40, and IL-4.
  • T cell-independent stimuli: LPS (TLR4) and IL-4.
  • Inhibitors: Rapamycin (mTORC1 inhibitor), MYCi361 (MYC inhibitor), and Deferiprone (iron chelator).
• Proteomics:
  • Identified and quantified >7,500 proteins.
  • Used the Proteomic Ruler algorithm to estimate absolute copy numbers per cell.
  • Utilized both Data-Dependent Acquisition (DDA) and Data-Independent Acquisition (DIA) mass spectrometry for comprehensive coverage.
• Validation:
  • Flow Cytometry: Used to measure cell size (FSC), surface markers (CD69, CD71, CD98), protein synthesis rates (OPP incorporation), and amino acid uptake (Kynurenine assay).
  • Genetic Models: Validated findings using conditional knockout mice for Slc7a5 and Myc.

3. Key Contributions

• First Quantitative Proteomic Map: Provided the first absolute copy number estimates for >7,500 proteins in naïve vs. activated B cells, revealing a 5-fold increase in total cellular protein mass within 24 hours of activation.
• Metabolic Dependency Mapping: Identified the critical role of the System L amino acid transporter SLC7A5 and the transferrin receptor CD71 as non-redundant drivers of B cell activation.
• Regulatory Hierarchy: Defined the regulatory axis where mTORC1 controls MYC expression, which in turn regulates iron uptake (CD71) and ribosomal biogenesis, but noted distinct cell-type specificities (e.g., SLC7A5 regulation differs between B and T cells).
• Stimulus Specificity: Mapped the synergistic effects of BCR, CD40, and IL-4, distinguishing them from TLR4-driven activation.

4. Key Results

A. Global Proteome Remodeling

• Mass Expansion: Activated B cells increased total protein mass 5-fold. The top 50% of protein mass shifted from being dominated by histones and cytoskeletal proteins (in naïve cells) to being dominated by ribosomal and translational machinery (in activated cells).
• Differential Expression: >5,000 proteins increased significantly (>1.5-fold). Key upregulated proteins included activation markers (CD86, CD69), cell cycle regulators (Cyclins, CDKs), and transcription factors (IRF4, IRF8, EGR2, NFIL3).
• Downregulation: Quiescence regulators (KLF2) and translation repressors (PDCD4, p27/CDKN1B) were degraded or downregulated.

B. Metabolic and Mitochondrial Remodeling

• Nutrient Transporters: Massive upregulation of glucose (SLC2A1), lactate (SLC16A1), and amino acid transporters (SLC1A5, SLC7A5).
• Iron Demand: The iron requirement per cell increased 7-fold (from ~5 million to ~35 million iron atoms/cell) to support DNA synthesis, histone modification, and mitochondrial function. This was matched by a massive upregulation of the transferrin receptor CD71 (from ~3,000 to ~500,000 copies/cell).
• Mitochondria: Total mitochondrial protein mass increased ~6-fold. Notably, mitochondrial ribosomes increased 3-fold relative to total mitochondrial mass, indicating active mitochondrial protein synthesis.

C. Synergy of Stimuli (BCR + CD40 + IL-4)

• Additive Effects: While individual stimuli (anti-IgM, anti-CD40, or IL-4) had modest effects, their combination triggered maximal expression of glycolytic enzymes, ribosomal proteins, and cell cycle machinery.
• T-Dependent vs. T-Independent: T cell-dependent activation (Anti-IgM/CD40/IL-4) induced a much larger proteome remodeling (median 7.4-fold increase) compared to T cell-independent (LPS/IL-4, median 2.4-fold). T-dependent activation uniquely upregulated fate-determining transcription factors (AHR, BACH2, EGR2) and VAV3, while LPS uniquely induced interferon-stimulated genes (IFIT1, ISG15).

D. The mTORC1 - MYC - Iron Axis

• mTORC1 Inhibition (Rapamycin):
  • Reduced total protein mass by ~50% and impaired protein synthesis rates.
  • Downregulated >4,700 proteins, including ribosomal proteins, mitochondrial proteins, and key transcription factors (IRF4, IRF8, AHR).
  • Crucially: Reduced expression of nutrient transporters SLC7A5 and CD71, and impaired amino acid uptake.
• MYC Inhibition (MYCi361 or Deletion):
  • Phenocopied mTORC1 inhibition regarding ribosomal mass, DNA replication machinery, and CD71 expression.
  • Key Distinction: Unlike mTORC1 inhibition, MYC inhibition did not reduce the abundance of SLC7A5 or SLC2A1. This indicates that while MYC regulates CD71, SLC7A5 expression in B cells is mTORC1-dependent but MYC-independent (unlike in T cells).
• Iron Chelation:
  • Depleting iron via Deferiprone impaired B cell growth and protein synthesis, confirming that the mTORC1/MYC-driven upregulation of CD71 is essential for providing the iron required for activation.

5. Significance

• Mechanistic Insight: The study establishes a direct mechanistic link between mTORC1 signaling, MYC transcriptional activity, and the metabolic capacity (specifically iron and amino acid uptake) required for B cell proliferation.
• Therapeutic Implications: By identifying SLC7A5 and CD71 as critical, non-redundant nodes in B cell activation, the study highlights potential targets for treating B cell malignancies or autoimmune diseases.
• Cell-Type Specificity: The finding that SLC7A5 regulation differs between B cells (mTORC1-dependent, MYC-independent) and T cells (MYC-dependent) underscores the necessity of cell-type-specific metabolic mapping.
• Resource: The authors have made the dataset publicly available via the Immunological Proteome Resource (Immpres), providing a foundational reference for the immune research community.

In conclusion, this work provides a high-resolution, quantitative blueprint of how B cells rewire their proteome to support immune activation, revealing that the metabolic checkpoint kinase mTORC1 orchestrates this process largely by driving MYC-dependent iron uptake and mTORC1-dependent amino acid transport.